Results 81 to 90 of about 220,753 (136)

KG-bench: benchmarking graph neural network algorithms for drug repurposing. [PDF]

Bioinformatics
Wei S, Sasi C, Piepenbrock J, Huynen MA, 't Hoen PAC, SIMPATHIC Consortium.   +5 more
europepmc   +1 more source

The German Cancer Consortium (DKTK) multi-center prospective phase 1/2 ⁶⁸Ga-PSMA-11 PET-imaging trial in newly-diagnosed high-risk prostate cancer: Safety and diagnostic accuracy compared to histopathology and their impact on patient management. [PDF]

Eur J Nucl Med Mol Imaging
Giesel FL, Koerber SA, Hadaschik B, Kiefer S, Schwarzenboeck S, Rahbar K, Derlin T, Grott CA, Heck M, Jilg C, Meyer PT, Ruf J, Schmidt K, Kotzerke J, la Fougère C, Reischl G, Virgolini I, Herrmann K, Burger IA, Lorenzini T, Werner M, Stenzinger A, Schwamborn K, Radtke JP, Hohenfellner M, Debus J, Weber WA, Haberkorn U, Kopka K, Eiber M, 68Ga-PSMA-11 DKTK trial contributors.   +30 more
europepmc   +1 more source

General anaesthesia <i>versus</i> monitored anaesthesia care and postoperative outcome in patients with elevated right ventricular systolic pressure undergoing low-risk surgical procedures: a retrospective single-centre cohort study. [PDF]

BJA Open
Nourian MM, Delaporte A, Wingert T, Boulos NM, Grogan T, Methangkool E, Neelankavil J, Saddic LA, Cannesson M, Mercier O, Umar S, Humbert M, Savale L, Joosten A.   +13 more
europepmc   +1 more source

Paediatric Phase I/II Clinical Trial Assessments Under the New EU Clinical Trial Regulation: A Descriptive Analysis. [PDF]

Pharmaceut Med
Fankhauser L, Ligas F, Lesa G, Karlsen AS, Lunzer M, Al M, Scherer S, Benchetrit S, Riedel C, Kopp-Schneider A, Witt R, Witt O, Karres D, van Tilburg CM.   +13 more
europepmc   +1 more source

Diagnostic performance of β-(1→3)-D-glucan, two <i>Candida</i> antigen, and five anti-<i>Candida</i> antibody assays in ICU patients with sepsis and high risk for invasive candidiasis: a secondary endpoint of the CandiSep randomized clinical trial. [PDF]

J Clin Microbiol
Standl L, Huber T, Bloos F, Thomas-Rüddel D, Träger J, Kluge S, Fichtner F, Simon P, Kogelmann K, de Heer G, Kuhn S, Jarczak D, Motsch J, Hempel G, Weiler N, Weyland A, Drüner M, Gründling M, Meybohm P, Richter D, Moerer O, Günther U, Schädler D, Zarbock A, Putensen C, Castellanos I, Kurzai O, Schlattmann P, Cornely OA, Bauer M, Lehmann T, Valenza G, Bogdan C, Held J, SepNet Critical Care Trials Group.   +34 more
europepmc   +1 more source

Criterion and Construct Validity of the Pocket-Worn RISE Device to Assess Movement Behaviour in Community-Dwelling People with Stroke. [PDF]

Sensors (Basel)
Biemans CFM, van der Heiden L, Veenhof C, Verschuren OW, Visser-Meily JMA, Pisters MF, Hartman YAW.   +6 more
europepmc   +1 more source

Healthcare resource utilization and costs of letermovir for cytomegalovirus-prophylaxis after allogeneic hematopoietic cell transplantation in a real-world, multi-centre study in Germany. [PDF]

Eur J Health Econ
Engelhard M, Wingen-Heimann SM, Classen AY, Blau IW, Bug G, Hebermehl C, Kraus S, Penack O, Rettig AR, Schmitt T, Steinbrunn T, Teschner D, Vehreschild MJGT, Wehr C, Vehreschild JJ, Pütz SM.   +15 more
europepmc   +1 more source

External validation of a multiple sclerosis treatment decision score using data from the ProVal-MS cohort study. [PDF]

Ther Adv Neurol Disord
Buchka S, Hapfelmeier A, Kirschke JS, Steuerwald V, Naumann M, Soto-Rey I, Rohr SO, Kramer F, Behrens L, Oswald E, Kümpfel T, Zimmermann H, Hoffmann VS, Hagedorn M, Albashiti F, Krumbholz M, Ziemann U, Kohlbacher O, Sailer B, Braunmüller V, Biergans S, de Arruda Botelho Herr M, Ernemann U, Bürkle E, Bender B, Daul A, Ruff C, Römhild J, Wiestler B, Sepp D, Spengler H, Pallaoro P, Boeker M, Kohlmayer F, Dehmelt V, Berthele A, Mühlau M, Uibel P, Wauschkuhn J, Kuhn K, Senel M, Vardakas I, Taranu D, Kestler HA, Sollmann N, Irmak Ön B, Bilger S, Mansmann U, Bayas A, Havla J, Kowarik MC, Tumani H, Hemmer B, ProVal-MS Study Group.   +53 more
europepmc   +1 more source

Long-term immune recovery under continuous antiretroviral therapy (ART) among ART-naive people living with HIV in two cohorts in Germany. [PDF]

Infection
Koppe U, Pörtner K, Kollan C, Pantke A, Sailer A, Dehmel K, Esser S, Jensen BO, Rockstroh JK, Schäfer G, Schürmann D, Stoll M, Wasmuth JC, Kurth T, Gunsenheimer-Bartmeyer B, HIV-1 Seroconverter Cohort and the ClinSurv-HIV Cohort.   +15 more
europepmc   +1 more source

Socioeconomic impact of depression and pain in patients with neuromyelitis optica spectrum disorders. [PDF]

Neurol Res Pract
Tkachenko D, Ayzenberg I, Schöppe LM, Schülke R, Paul F, Duchow A, Bellmann-Strobl J, Siebert N, Kümpfel T, Havla J, Pellkofer H, Jarius S, Wildemann B, Berthele A, Klotz L, Pawlitzki M, Gingele S, Schreiber-Katz O, Weber MS, Senel M, Stellmann JP, Häußler V, Aktas O, Ringelstein M, Hellwig K, Schwake C, Kleiter I, Trebst C, Hümmert MW, Neuromyelitis Optica Study Group (NEMOS)§.   +29 more
europepmc   +1 more source